Wilson David C, Russell Richard K
Child Life and Health, University of Edinburgh, Edinburgh EH9 1UW, Scotland, UK; Royal Hospital for Sick Children, Edinburgh, Scotland, UK.
Department of Paediatric Gastroenterology, Royal Hospital for Children, Glasgow, Scotland, UK.
Semin Pediatr Surg. 2017 Dec;26(6):344-348. doi: 10.1053/j.sempedsurg.2017.10.002. Epub 2017 Oct 4.
Inflammatory bowel disease (IBD) is a chronic complex disease of children and adults requiring a range of medications and surgical techniques to induce and maintain remission. In common with other immune-mediated inflammatory disorders, it has shown an ever-increasing rise in incidence worldwide over the last 50 years. The cause of IBD arises from interactions between the microbiome in the gut and the gastrointestinal and systemic immune system in genetically susceptible persons, and with environmental triggers to both develop IBD and have relapses of IBD. The burden of IBD in children and adolescents can be high, and treatment needs a multi-disciplinary approach aiming to abolish symptoms, promote growth and development, and support a restriction-free life. Achieving healing of the intestinal mucosa promotes long-term remission and helps to avoid disease complications.
炎症性肠病(IBD)是一种发生于儿童和成人的慢性复杂疾病,需要一系列药物和手术技术来诱导并维持缓解。与其他免疫介导的炎症性疾病一样,在过去50年里,其在全球范围内的发病率呈持续上升趋势。IBD的病因源于肠道微生物群与遗传易感性个体的胃肠道及全身免疫系统之间的相互作用,以及导致IBD发生和复发的环境触发因素。儿童和青少年IBD的负担可能很重,治疗需要采取多学科方法,旨在消除症状、促进生长发育并支持无限制的生活。实现肠黏膜愈合可促进长期缓解,并有助于避免疾病并发症。